Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI and Clinical Disease Activity in Patients Treated Long Term With Natalizumab

NCT02677077 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT02677077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02677077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI and Clinical Disease Activity in Patients Treated Long Term With Natalizumab
Lead sponsor
Biogen
Phase
Observational
Overall status
Completed
Start date
December 31, 2015
Completion date
August 18, 2016
Enrollment
277 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis